TranSenda Joins MicroSoft's BioIT Alliance | GenomeWeb
NEW YORK (GenomeWeb News) - Clinical trial software firm TranSenda said last week that it has joined the BioIT Alliance — a consortium of industry partners created in April with the aim of improving biomedical information technology on the Microsoft platform.
 
Microsoft selected TranSenda to join the BioIT Alliance “because of its continued excellence in using Microsoft .NET-based technologies to build process-based, integrated solutions,” the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.